Oxford University Press provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of Stem Cells Translational Medicine (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Stem Cells Translational Medicine published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Cell & Tissue Engineeringrank 10 of 35 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Stem Cells Translational Medicine
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Stem Cells Translational Medicine is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Open access (listed in DOAJ); article processing charge listed at about US$2,963.
02Fee waivers
APC waivers and discounts for Stem Cells Translational Medicine
Stem Cells Translational Medicine follows the waiver policy of its publisher, Oxford University Press: automatic waiver or discount in fully open access journals by an EIFL and Research4Life based country list. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver.
Authors affiliated in 25 countries qualify for a full waiver. See the countries →
Waivers apply to fully open access journals. If Stem Cells Translational Medicine is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Retractions and research integrity at Stem Cells Translational Medicine
Most common reasons (a retraction can have several):
Stem Cells Translational Medicine has 2 retracted papers in the Retraction Watch database, the latest in Nov 2021. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
Who funds research published in Stem Cells Translational Medicine
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
Submitting to Stem Cells Translational Medicine? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
03Indexing
Indexing of Stem Cells Translational Medicine
- ISSN
- 2157-6564
- eISSN
- 2157-6580
- Publisher
- Oxford University Press all its journals →
- Country
- United States
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Cell & Tissue Engineering
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
- Web of Science Master Journal List
- SCImago Journal Rank
- ISSN Portal (ISSN 2157-6564)
- DOAJ (Directory of Open Access Journals)
Each link opens the official record for this journal, searched by its ISSN where we have one.
04How to submit
How to submit to Stem Cells Translational Medicine
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Stem Cells Translational Medicine accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Use the journal's template. Oxford University Press offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
- Check the fit. Compare your title and abstract with the papers it has published; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Plan the fee. Stem Cells Translational Medicine is fully open access, with an article fee of about US$2,963 after acceptance. See whether your author team qualifies for a waiver with the free APC waiver checker.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
05What it publishes
What Stem Cells Translational Medicine publishes: real papers
06Published papers
Papers published in Stem Cells Translational Medicine
Papers from the publication records ScholarsColab tracks, with their year and citations. Author names are not shown.
- TISSUE-SPECIFIC PROGENITOR AND STEM CELLS20160 citations
07Reviewer comments
Reviewer comments and rejection reasons for Stem Cells Translational Medicine
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Stem Cells Translational Medicine, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
08Similar journals
Journals similar to Stem Cells Translational Medicine
Journals that publish the closest work to the papers above, from the indexing lists:
- PeerJSCIEScopusJCR 202422 similar papers
- PLoS ONESCIEScopusJCR 202447 similar papers
- PLoS Computational BiologySCIEScopusJCR 20249 similar papers
- Frontiers in Cell and Developmental BiologySCIEScopusJCR 202411 similar papers
- Frontiers in ImmunologySCIEScopusJCR 202419 similar papers
- Frontiers in NeurologySCIEScopusJCR 20244 similar papers
09Same subject
Cell & Tissue Engineering journals with a similar impact factor*
The journals next to Stem Cells Translational Medicine when the 32 journals of Cell & Tissue Engineering in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 6 | European Cells and Materials | 6.07 | SCIE | Fully open access |
| 7 | Regenerative Therapy | 5.35 | SCIE | Fully open access |
| 8 | Cell Regeneration | 5.16 | ESCI | Fully open access |
| 9 | Stem Cell Reports | 5.09 | SCIE | Fully open access |
| 11 | Stem Cell Reviews and Reports | 4.48 | SCIE | Subscription |
| 12 | Tissue Engineering and Regenerative Medicine | 4.27 | SCIE | Subscription |
| 13 | Stem Cells | 3.86 | SCIE | Subscription |
| 14 | Cell Transplantation | 3.73 | SCIE | Fully open access |
*Impact factor calculated from OpenAlex open data (2-year citedness), not the official Clarivate value.
10Journal Finder
Find the right journal for your paper
Is Stem Cells Translational Medicine right for your paper? Compare journals
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,503 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated from OpenAlex open data, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time comes from the dates publishers deposit in Crossref (not every publisher deposits them). Always check a journal’s scope and current indexing before submitting.
11Questions
Frequently asked questions
What is the impact factor of Stem Cells Translational Medicine?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Stem Cells Translational Medicine is 4.69: papers it published in the two previous years were cited 4.69 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Stem Cells Translational Medicine?
The h-index of Stem Cells Translational Medicine is 130 (OpenAlex, October 2026): 130 of its papers have each been cited at least 130 times. Its i10-index is 1,495.
What is the APC of Stem Cells Translational Medicine?
OpenAlex lists an article processing charge (APC) of about US$2,963 for Stem Cells Translational Medicine, an open access journal (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of Stem Cells Translational Medicine?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Stem Cells Translational Medicine is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Stem Cells Translational Medicine indexed in Scopus?
Yes. Stem Cells Translational Medicine appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Stem Cells Translational Medicine an SCIE journal?
Yes. Stem Cells Translational Medicine is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Stem Cells Translational Medicine in Journal Citation Reports (JCR)?
Yes. Stem Cells Translational Medicine is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
How many papers published in Stem Cells Translational Medicine does ScholarsColab track?
We track 1 paper published in Stem Cells Translational Medicine in 2016, cited 0 times in total, with a median of 0 citations per paper.
Does Stem Cells Translational Medicine offer an APC waiver?
Stem Cells Translational Medicine follows the policy of Oxford University Press: automatic waiver or discount in fully open access journals by an EIFL and Research4Life based country list. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Has Stem Cells Translational Medicine retracted papers?
Yes. The Retraction Watch database lists 2 retracted papers in Stem Cells Translational Medicine, 2 of them in the last 10 years; the most common reasons are breach of policy by author, miscommunication with/by journal/publisher, concerns/issues about image. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in Stem Cells Translational Medicine?
81% of 195 recent research articles in Stem Cells Translational Medicine name a funder in Crossref; the funders named most often are National Natural Science Foundation of China, National Institutes of Health, National Key Research and Development Program of China.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Medical Physics
- Tetrahedron
- Journal of Bacteriology
- Chemical Physics Letters
- Materials Science and Engineering: A
- Solid State Communications
- Cancer Research
- ACS Applied Materials and Interfaces
- Frontiers in Immunology
- Alzheimer's and Dementia
- European journal of cancer
- Investigative Ophthalmology and Visual Science
- Fuel
- Transplantation
Browse all journals: indexing, impact factor and reviewer comments →